Skip to main content
Paul Hahn, MD, Ophthalmology, Nanuet, NY

Paul Hahn MD PhD

Retinal Disease


Founder, phRETINA

Join to View Full Profile
  • 25 Smith StSte 414Nanuet, NY 10954

  • Phone+1 845-335-7234

  • Fax+1 845-335-7237

Dr. Hahn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Surgical Retina and Vitreous, 2010 - 2012
  • University of Pennsylvania Health System/Scheie Eye Institute
    University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 2007 - 2010
  • Presbyterian Medical Center of the University of Pennsylvania Health System
    Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 2006 - 2007
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2006
  • University of Pennsylvania School of Medicine
    University of Pennsylvania School of MedicinePh.D, Molecular Pharmacology, 2000 - 2004

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2015 - 2027
  • NY State Medical License
    NY State Medical License 2022 - 2027
  • NC State Medical License
    NC State Medical License 2010 - 2016
  • PA State Medical License
    PA State Medical License 2006 - 2010
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification IntelleChart, MDIntelleSys, A Nextech Company, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Deficiency of Bax and Bak protects photoreceptors from light damage in vivo.  
    Hahn P, Lindsten T, Lyubarsky A, Ying GS, Pugh EN, Thompson CB, Dunaief JL, Cell Death Differ
  • Retinal localization and copper-dependent re-localization of the Wilson and Menkes disease proteins.  
    Krajacic P, Qian Y, Hahn P, Dentchev T, Gitlin J, and Dunaief JL, Invest Ophthalmol Vis Sci
  • Peripheral Retinal Vasculitis Demonstrated by Ultra-widefield Fluorescein Angiography in Preeclampsia with HELLP Syndrome.  
    Lin P, Hahn P, Fekrat S, Retina

Books/Book Chapters

Abstracts/Posters

  • Initial Experience With Human Imaging Of Vitreoretinal Surgical Maneuvers Using A Custom Microscope-Mounted Spectral Domain Optical Coherence Device.
    Hahn P, Migacz J, O’Connell R, Yuan E, Moreno T, Izatt JA, Toth CA, ARVO Meeting Abstracts
  • Ceruloplasmin/Hephaestin Knockout Mice Model Morphologic and Mechanistic Features of AMD.
    Hadziahmetovic M, Song Y, Dentchev T, Haddad N, He X, Hahn P, Wen R, Dunaief JL, ARVO Meeting Abstracts
  • Correlation of Tissue Iron Levels With Age in C57BL/6, DBA/J, and Balb/c Mice.
    Hahn P, Song Y, He X, Beard J, Dunaief JL, ARVO Meeting Abstracts

Other

  • Increased expression of ceruloplasmin in the retina following photic injury. 
    Chen L, Dentchev T, Wong R, Hahn P, Wen R, Bennett J, Dunaief JL, Mol Vis
  • Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. 
    Hahn P, Qian Y, Dentchev T, Chen L, Beard J, Harris ZL, Dunaief JL, Proc Natl Acad Sci USA
  • Strong photoreceptor label for iron and the iron handling proteins ferritin and ferroportin in age-related macular degeneration. 
    Dentchev T, Hahn P, Dunaief JL, Arch Ophthalmol

Press Mentions

  • Novartis Update on Patients Suffering from Retinal Vasculitis and/or Retinal Vascular Occlusion After Beovu Injections
    Novartis Update on Patients Suffering from Retinal Vasculitis and/or Retinal Vascular Occlusion After Beovu InjectionsNovember 17th, 2020
  • Practical Concepts with the Argus II Retinal Prosthesis
    Practical Concepts with the Argus II Retinal ProsthesisOctober 19th, 2018
  • Managing Coexisting Anterior and Posterior Conditions
    Managing Coexisting Anterior and Posterior ConditionsJune 1st, 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: